Top compounds associated with response to KRT79


Feature Type Standardized
Nominal ANOVA
mRNA SJ-172550 CTRPv2 pan-cancer AAC 0.27 3e-14
mRNA azacitidine CTRPv2 pan-cancer AAC 0.22 6e-10
mRNA linifanib GDSC1000 pan-cancer AAC 0.13 0.0002
mRNA Doxorubicin gCSI pan-cancer AAC -0.21 0.0002
mRNA KIN001-102 GDSC1000 pan-cancer AAC 0.11 0.0003
mRNA Gemcitabine gCSI pan-cancer AAC -0.2 0.001
mRNA Docetaxel gCSI pan-cancer AAC -0.19 0.002
mRNA paclitaxel gCSI pan-cancer AAC -0.19 0.002
mRNA Vorinostat gCSI pan-cancer AAC -0.18 0.002
mRNA PD-0325901 gCSI pan-cancer AAC 0.17 0.003
Download CSV